Market Research

Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3 Billion Globally in 2018: Transparency Market Research … continue reading “Artificial Vital Organs and Medical Bionics Market to Reach USD 32.3 Bn in 2018”

Orthopaedic product sales exceeded $43 billion in 2012, a modest increase of 3% or $1.2 billion over 2011, according to market intelligence specialist ORTHOWORLD®. Segments contributing greatest growth included trauma at $6.1 billion and sports medicine at $4.2 billion. Spine posted negative growth, while hips, knees, extremities and orthobiologics posted growth in the low-single digits.

Market intelligence company Millennium Research Group (MRG), reckons the 2013 Japanese launch of transcatheter aortic valve implants, will spur accelerating growth in the market. Earthquakes, the tsunami and economic factors might hold things back a bit though.

A recent Europe-wide survey of Anaesthetists, delivered by UK medical device research firm Creative Medical Research, claims to have revealed the views of the profession in relation to existing and future technologies.

In short A new report, another on the subject of renal denervation(RDN), claims the world market for these devices is … continue reading “New Report Looks Into Global RDN Devices Crystal Ball”

Creative Medical Research (CMR), a fast growing UK-based business focusing on innovative research into the medical device market, has recently begun a comprehensive survey of 100 anaesthetists across Europe into their awareness and prediction of technological advances.

We’ll probably get responses from angry market intelligence companies claiming their work is brilliant and important. What will be more interesting will be to see if the purchasers of these things feel the same way. OK, it’s personal, but I don’t think I’m entirely a lone voice.

Does anyone inside the industry really know what the future holds for Renal Denervation? It’s a technology that is just at the starting line and very much entering shake-out phase. We’ve no idea what the market will look like in 2021, but this new report promises crystal ball properties.

Medtech intelligence company Millennium Research Group says the European interventional cardiology market will barely grow through 2017. Growth will however come from bioresorbable stents and intravascular imaging.

Growth in HA viscosupplementation will be driven by rising Global rates of osteoarthritis and obesity, according to a Millennium Research Group report. The company says the market could reach $2.5Bn by 2017.

U.S. market intelligence company Millennium Research Group has issued a new report into vascular disease trends in the Middle East and reckons obesity is a key driver for future vascular therapies in the region. Dunno why but I have an image of a supersized
American wagging his finger at a well-built Arab and calling him fat.

UK based MIS device company Surgical Innovations (SI) chose last week’s International Society of Hip Arthroscopy (ISHA) meeting in Boston, at which to showcase its pre-production hip arthroscopy products.

The European market for transcatheter embolization devices is valued at just over €230 million with the leading segment consisting of coil embolics, which currently represents nearly half of the market. A new report from iData Research points to growth in endovascular procedures in general with aging population and growth in predisposing conditions the main drivers.

Ageing population, improved screening and new treatments will drive GI Endoscopy market in U.S.A

Market intelligence company Millennium Research Group, reckons the U.S. Transcatheter Embolisation and Occlusion device market will grow at an average annual rate of just over nine percent through 2016, driven by an aging population and a trend away from traditional surgical procedures and toward minimally invasive procedures, with particular growth in aneurysm treatment.

It’s all a bit weird. Companies issue press releases containing information about their rosy prospects all the time, but they don’t often charge you for the privilege of reading them. Tissue Regeneration Technologies obviously has other ideas.